REGENXBIO Inc.

RGNX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$62-$71$6-$51
Dep. & Amort.$4$4$4$4
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$9$9$10
Change in WC-$10$8$16$12
Other Non-Cash$12$1-$1-$6
Operating Cash Flow-$56-$49$34-$32
Investing Activities
PP&E Inv.-$0-$0-$1-$1
Net Acquisitions$0$0$0$0
Inv. Purchases-$40-$211-$19-$16
Inv. Sales/Matur.$82$71$65$58
Other Inv. Act.$0$0$0$0
Investing Cash Flow$42-$140$45$40
Financing Activities
Debt Repay.-$145$145$0$0
Stock Issued$145-$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$8-$5-$6-$8
Financing Cash Flow-$7$139-$6-$8
Forex Effect$0$0$0$0
Net Chg. in Cash-$21-$51$73$1
Supplemental Information
Beg. Cash$80$132$60$59
End Cash$59$82$132$60
Free Cash Flow-$56-$50$33-$33